When administering Ondansetron, what is the maximum dose allowable and what are the routes?

The maximum allowable dose of Ondansetron when administered IV/IO or as an ODT (Orally Disintegrating Tablet) PO is indeed 8 mg, which can be repeated in 15-20 minutes if necessary. This dosing regimen is important as Ondansetron is commonly used in emergency settings to prevent nausea and vomiting, especially in cases such as chemotherapy or postoperative care.

The option detailing the maximum dosing provides flexibility for patient needs while adhering to safety guidelines. Since Ondansetron works as an antiemetic by blocking serotonin receptors, understanding the routes of administration is critical as it affects the onset of action and patient management strategies. The intravenous/intraosseous route provides rapid relief, which is particularly beneficial in acute situations. The orally disintegrating tablet offers a convenient alternative for patients who may not be able to swallow pills.

The other choices outline incorrect routes or dosages that do not align with current protocols for administering Ondansetron, which emphasizes the importance of adhering to evidence-based dosages and administration methods. Thus, understanding both the maximum allowable dose and the appropriate routes is essential for effective patient care in emergency medical situations.